The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Contraceptive Drugs Market Research Report 2025
Synopsis
Contraceptives are a kind of medicine used to prevent unwanted pregnancy. It consists of one or more synthetic female sex hormones. These sex hormones prevent pregnancy by blocking the normal process of ovulation.
The global Oral Contraceptive Drugs market was valued at US$ 12450 million in 2023 and is anticipated to reach US$ 19660 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.
The contraceptives market is driven by the increasing awareness and adoption of family planning methods to control population growth and improve maternal and child health. Contraceptives provide individuals with choices for safe and effective birth control, leading to a decline in unintended pregnancies and a healthier reproductive population. Moreover, government initiatives and awareness campaigns aimed at promoting family planning further contribute to market growth. However, challenges include cultural and social barriers, lack of access to contraceptives in certain regions, and potential side effects associated with some contraceptive methods. Addressing these challenges through education, improved access to contraceptives, and the development of innovative and user-friendly contraceptive options will be crucial for sustaining the growth of the contraceptives market.
This report aims to provide a comprehensive presentation of the global market for Oral Contraceptive Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Contraceptive Drugs.
Report Scope
The Oral Contraceptive Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Contraceptive Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Contraceptive Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Pfizer
Teva Pharmaceutical
Merck
Actavis
Johnson & Johnson
Gedeon Richter
Novo Nordisk A/S
ZiZhu
Baijingyu
Huazhong
Segment by Type
Long-acting Contraceptives
Short-acting Contraceptives
Emergency Contraceptives
Segment by Application
Hospital
Pharmacy
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Contraceptive Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Contraceptive Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Contraceptives are a kind of medicine used to prevent unwanted pregnancy. It consists of one or more synthetic female sex hormones. These sex hormones prevent pregnancy by blocking the normal process of ovulation.
The global Oral Contraceptive Drugs market was valued at US$ 12450 million in 2023 and is anticipated to reach US$ 19660 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.
The contraceptives market is driven by the increasing awareness and adoption of family planning methods to control population growth and improve maternal and child health. Contraceptives provide individuals with choices for safe and effective birth control, leading to a decline in unintended pregnancies and a healthier reproductive population. Moreover, government initiatives and awareness campaigns aimed at promoting family planning further contribute to market growth. However, challenges include cultural and social barriers, lack of access to contraceptives in certain regions, and potential side effects associated with some contraceptive methods. Addressing these challenges through education, improved access to contraceptives, and the development of innovative and user-friendly contraceptive options will be crucial for sustaining the growth of the contraceptives market.
This report aims to provide a comprehensive presentation of the global market for Oral Contraceptive Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Contraceptive Drugs.
Report Scope
The Oral Contraceptive Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Contraceptive Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Contraceptive Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Pfizer
Teva Pharmaceutical
Merck
Actavis
Johnson & Johnson
Gedeon Richter
Novo Nordisk A/S
ZiZhu
Baijingyu
Huazhong
Segment by Type
Long-acting Contraceptives
Short-acting Contraceptives
Emergency Contraceptives
Segment by Application
Hospital
Pharmacy
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Contraceptive Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Contraceptive Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Oral Contraceptive Drugs Market Overview
1.1 Product Overview and Scope of Oral Contraceptive Drugs
1.2 Oral Contraceptive Drugs Segment by Type
1.2.1 Global Oral Contraceptive Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Long-acting Contraceptives
1.2.3 Short-acting Contraceptives
1.2.4 Emergency Contraceptives
1.3 Oral Contraceptive Drugs Segment by Application
1.3.1 Global Oral Contraceptive Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Oral Contraceptive Drugs Market Size Estimates and Forecasts
1.4.1 Global Oral Contraceptive Drugs Revenue 2019-2030
1.4.2 Global Oral Contraceptive Drugs Sales 2019-2030
1.4.3 Global Oral Contraceptive Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oral Contraceptive Drugs Market Competition by Manufacturers
2.1 Global Oral Contraceptive Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oral Contraceptive Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oral Contraceptive Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Oral Contraceptive Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Contraceptive Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Contraceptive Drugs, Product Type & Application
2.7 Oral Contraceptive Drugs Market Competitive Situation and Trends
2.7.1 Oral Contraceptive Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Contraceptive Drugs Players Market Share by Revenue
2.7.3 Global Oral Contraceptive Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Contraceptive Drugs Retrospective Market Scenario by Region
3.1 Global Oral Contraceptive Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oral Contraceptive Drugs Global Oral Contraceptive Drugs Sales by Region: 2019-2030
3.2.1 Global Oral Contraceptive Drugs Sales by Region: 2019-2024
3.2.2 Global Oral Contraceptive Drugs Sales by Region: 2025-2030
3.3 Global Oral Contraceptive Drugs Global Oral Contraceptive Drugs Revenue by Region: 2019-2030
3.3.1 Global Oral Contraceptive Drugs Revenue by Region: 2019-2024
3.3.2 Global Oral Contraceptive Drugs Revenue by Region: 2025-2030
3.4 North America Oral Contraceptive Drugs Market Facts & Figures by Country
3.4.1 North America Oral Contraceptive Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oral Contraceptive Drugs Sales by Country (2019-2030)
3.4.3 North America Oral Contraceptive Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oral Contraceptive Drugs Market Facts & Figures by Country
3.5.1 Europe Oral Contraceptive Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oral Contraceptive Drugs Sales by Country (2019-2030)
3.5.3 Europe Oral Contraceptive Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Contraceptive Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Contraceptive Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oral Contraceptive Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Oral Contraceptive Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oral Contraceptive Drugs Market Facts & Figures by Country
3.7.1 Latin America Oral Contraceptive Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oral Contraceptive Drugs Sales by Country (2019-2030)
3.7.3 Latin America Oral Contraceptive Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Contraceptive Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Contraceptive Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oral Contraceptive Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oral Contraceptive Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Oral Contraceptive Drugs Sales by Type (2019-2030)
4.1.1 Global Oral Contraceptive Drugs Sales by Type (2019-2024)
4.1.2 Global Oral Contraceptive Drugs Sales by Type (2025-2030)
4.1.3 Global Oral Contraceptive Drugs Sales Market Share by Type (2019-2030)
4.2 Global Oral Contraceptive Drugs Revenue by Type (2019-2030)
4.2.1 Global Oral Contraceptive Drugs Revenue by Type (2019-2024)
4.2.2 Global Oral Contraceptive Drugs Revenue by Type (2025-2030)
4.2.3 Global Oral Contraceptive Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Oral Contraceptive Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oral Contraceptive Drugs Sales by Application (2019-2030)
5.1.1 Global Oral Contraceptive Drugs Sales by Application (2019-2024)
5.1.2 Global Oral Contraceptive Drugs Sales by Application (2025-2030)
5.1.3 Global Oral Contraceptive Drugs Sales Market Share by Application (2019-2030)
5.2 Global Oral Contraceptive Drugs Revenue by Application (2019-2030)
5.2.1 Global Oral Contraceptive Drugs Revenue by Application (2019-2024)
5.2.2 Global Oral Contraceptive Drugs Revenue by Application (2025-2030)
5.2.3 Global Oral Contraceptive Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Oral Contraceptive Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Oral Contraceptive Drugs Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Oral Contraceptive Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Teva Pharmaceutical
6.3.1 Teva Pharmaceutical Corporation Information
6.3.2 Teva Pharmaceutical Description and Business Overview
6.3.3 Teva Pharmaceutical Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Pharmaceutical Oral Contraceptive Drugs Product Portfolio
6.3.5 Teva Pharmaceutical Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Oral Contraceptive Drugs Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Actavis
6.5.1 Actavis Corporation Information
6.5.2 Actavis Description and Business Overview
6.5.3 Actavis Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Actavis Oral Contraceptive Drugs Product Portfolio
6.5.5 Actavis Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Johnson & Johnson Oral Contraceptive Drugs Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Gedeon Richter
6.6.1 Gedeon Richter Corporation Information
6.6.2 Gedeon Richter Description and Business Overview
6.6.3 Gedeon Richter Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Gedeon Richter Oral Contraceptive Drugs Product Portfolio
6.7.5 Gedeon Richter Recent Developments/Updates
6.8 Novo Nordisk A/S
6.8.1 Novo Nordisk A/S Corporation Information
6.8.2 Novo Nordisk A/S Description and Business Overview
6.8.3 Novo Nordisk A/S Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Novo Nordisk A/S Oral Contraceptive Drugs Product Portfolio
6.8.5 Novo Nordisk A/S Recent Developments/Updates
6.9 ZiZhu
6.9.1 ZiZhu Corporation Information
6.9.2 ZiZhu Description and Business Overview
6.9.3 ZiZhu Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ZiZhu Oral Contraceptive Drugs Product Portfolio
6.9.5 ZiZhu Recent Developments/Updates
6.10 Baijingyu
6.10.1 Baijingyu Corporation Information
6.10.2 Baijingyu Description and Business Overview
6.10.3 Baijingyu Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Baijingyu Oral Contraceptive Drugs Product Portfolio
6.10.5 Baijingyu Recent Developments/Updates
6.11 Huazhong
6.11.1 Huazhong Corporation Information
6.11.2 Huazhong Oral Contraceptive Drugs Description and Business Overview
6.11.3 Huazhong Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Huazhong Oral Contraceptive Drugs Product Portfolio
6.11.5 Huazhong Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Contraceptive Drugs Industry Chain Analysis
7.2 Oral Contraceptive Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Contraceptive Drugs Production Mode & Process
7.4 Oral Contraceptive Drugs Sales and Marketing
7.4.1 Oral Contraceptive Drugs Sales Channels
7.4.2 Oral Contraceptive Drugs Distributors
7.5 Oral Contraceptive Drugs Customers
8 Oral Contraceptive Drugs Market Dynamics
8.1 Oral Contraceptive Drugs Industry Trends
8.2 Oral Contraceptive Drugs Market Drivers
8.3 Oral Contraceptive Drugs Market Challenges
8.4 Oral Contraceptive Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
